ATYR PHARMA
aTyr Pharma is a biotherapeutics company that discovers and develops protein biologics for human therapeutics. The company has established a dominant intellectual property estate surrounding Physiocrine-based compositions and potential therapeutic applications. aTyr’s key programs are focused on immunomodulation disorders in the areas of inflammation and immunity and are in preclinical development. The company's primary focus is ATYR1923, a clinical-stage product candidate which binds to the... neuropilin-2 receptor and is designed to down-regulate immune engagement in interstitial lung diseases. The privately held biotech was founded by The Scripps Research Institute Professor Paul Schimmel, a leading aminoacyl tRNA synthetase scientist, and is backed by top life sciences investors Alta Partners, Cardinal Partners, Domain Associates and Polaris Ventures.
ATYR PHARMA
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2005-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.atyrpharma.com
Total Employee:
51+
Status:
Active
Contact:
(858) 731-8389
Email Addresses:
[email protected]
Total Funding:
402.5 M USD
Technology used in webpage:
Domain Not Resolving Google Maps IPv6 ReCAPTCHA CrUX Top 50m ASP.NET IIS ASP.NET 4.0 Vimeo ASP.NET Ajax
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Amunix
Amunix is a biopharmaceutical company intended to discover, design, and develop novel biologics, protein, and peptide therapeutics.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
MediciNova
MediciNova is a biopharmaceutical company that acquires and develops novel, small-molecule therapeutics.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Viking Global Investors
Viking Global Investors investment in Post-IPO Equity - aTyr Pharma
Redmile Group
Redmile Group investment in Post-IPO Equity - aTyr Pharma
EcoR1 Capital
EcoR1 Capital investment in Post-IPO Equity - aTyr Pharma
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - aTyr Pharma
Solar capital
Solar capital investment in Post-IPO Debt - aTyr Pharma
Domain Associates
Domain Associates investment in Series E - aTyr Pharma
EcoR1 Capital
EcoR1 Capital investment in Series E - aTyr Pharma
Polaris Venture Capital
Polaris Venture Capital investment in Series E - aTyr Pharma
Alta Partners
Alta Partners investment in Series E - aTyr Pharma
Cardinal Partners
Cardinal Partners investment in Series E - aTyr Pharma
Key Employee Changes
Official Site Inspections
http://www.atyrpharma.com Semrush global rank: 2.95 M Semrush visits lastest month: 5.33 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "aTyr Pharma"
aTyr Pharma - Wikipedia
ATyr Pharma is a public biotherapeutics company (Nasdaq: LIFE) [1] that is focused on researching the extracellular functionality and signaling pathways of tRNA synthetases.. The …See details»
aTyr Pharma, Inc. (ATYR) Company Profile & Facts - Yahoo Finance
See the company profile for aTyr Pharma, Inc. (ATYR) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
aTyr Pharma Org Chart + Executive Team - The Official Board
Www.atyrpharma.com. has 19 executives +1 858 731 8389; Add an executive. Latest news on aTyr Pharma (ATYR) Anything missing? We search for you. Print or download . CEO & …See details»
aTyr Pharma - Crunchbase Company Profile & Funding
ATyr Pharma is a biotherapeutics company that discovers and develops protein biologics for human therapeutics. The company has established a dominant intellectual property estate …See details»
aTyr Pharma (ATYR) Company Profile & Description - Stock Analysis
May 7, 2015 aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into …See details»
aTyr Pharma - Overview, News & Similar companies - ZoomInfo
May 2, 2024 Who is aTyr Pharma. aTyr is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways. aTyr's resea …See details»
aTyr Pharma Information - RocketReach
ATyr Pharma (Nasdaq: LIFE) is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways. aTyr’s research and …See details»
aTyr Pharma - businessabc.net
Feb 25, 2025 aTyr Pharma was founded in 2005 as a spin-off from The Scripps Research Institute. Since then, the company has raised more than $230 million to advance its research …See details»
About Us - aTyr Pharma
ATyr is a clinical stage biotechnology company leveraging evolutionary intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation. tRNA synthetases …See details»
aTyr Pharma - Craft
Aug 6, 2024 aTyr Pharma has 4 employees at their 1 location and $235 k in annual revenue in FY 2024. See insights on aTyr Pharma including office locations, competitors, revenue, …See details»
Working At aTyr Pharma: Company Overview and Culture - Zippia
Mar 14, 2024 atyrpharma.com. Organization Type. Public. CEO. Sanjay S. Shukla. Social Media. aTyr Pharma develops biologic therapeutics based on Physiocrine biology. aTyr has …See details»
Investor Home | aTyr Pharma
May 19, 2025 aTyr Pharma is a clinical stage biotechnology company leveraging evolutionary intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation.See details»
aTyr Pharma - VentureRadar
"aTyr’s mission is to translate novel biological pathways to develop innovative therapeutics with improved outcomes for patients. Our focus is on the extracellular functionality and signaling …See details»
Leadership Team - aTyr Pharma
Our leadership team has a proven track record of discovering and developing breakthrough medicines from new areas of biology. We are utilizing our combined experiences and …See details»
aTyr Pharma | LinkedIn
ATyr Pharma (Nasdaq: LIFE) is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways. aTyr’s research and …See details»
Contact - aTyr Pharma
Corporate Headquarters 10240 Sorrento Valley Road, Suite 300 San Diego, California 92121 (858) 731-8389 Phone (858) 731-8394 Fax General InquiriesSee details»
Board of Directors - aTyr Pharma
ATyr’s Board of Directors plays an important strategic role in guiding our vision as a biotech company driven by innovation and the discovery of breakthrough scientific discoveries. Each …See details»
aTyr Pharma to be Added to the Russell 2000® and Russell 3000® …
18 hours ago SAN DIEGO, June 26, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the …See details»
aTyr Pharma to be Added to the Russell 2000® and Russell
18 hours ago SAN DIEGO, June 26, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the …See details»
aTyr Pharma Presents Preclinical Data for NRP2-Targeting …
Apr 29, 2025 For more information, please visit www.atyrpharma.com. Forward-Looking Statements. This press release contains forward-looking statements within the meaning of the …See details»